Drew Armstrong, the new executive editor of biopharmaceutical industry news site Endpoints News, said it would expand with six new positions.
Armstrong writes, “We’re a newsroom of experts focused on the biopharma industry – with the ability and ambition to compete with (and beat!) the biggest publications for scoops and smart analysis on our turf.
“To that end, we’re hiring: Today we’ve posted six new jobs at Endpoints that will expand the size and ambition of our newsroom. You can find the listings here (along with descriptions of our great benefits and our work-from-home/anywhere policy). We’re adding to our editing ranks, and plan to hire writers and reporters to boost our science, venture capital and regulatory coverage.
“We want people who are passionate about covering medical innovation and business, but also who see the journalism world the way we do: who believe that focus creates greatness, and that the next thriving newsrooms will be built by being smarter and breaking more news than anyone else on your beat.”
Read more here.
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…
CNBC.com deputy technology editor Todd Haselton is leaving the news organization for a job at The Verge.…
Note from CNBC Business News senior vice president Dan Colarusso: After more than 27 years…